Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

F. Martényi · SciRah

Researcher profile · Semantic Scholar

F. Martényi

Share profile

F. Martényi — researcher profile on SciRah

h-index: 21
Works: 71
Citations: 3,140

Most-cited papers

Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial
Sandeep T. Patil, Lu Zhang, F. Martényi, S. Lowe +14 more
2007Nature Medicine1,050 citations Open access
Semantic Scholar
Robust Central Reduction of Amyloid-β in Humans with an Orally Available, Non-Peptidic β-Secretase Inhibitor
P. May, R. Dean, S. Lowe, F. Martényi +21 more
2011Journal of Neuroscience348 citations Open access
Semantic Scholar
Estimating Alzheimer’s Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia
Matthew Davis, Thomas O’Connell, Scott J. Johnson, S. Cline +3 more
2018Current Alzheimer Research212 citations Open access
Semantic Scholar
Fluoxetine versus placebo in posttraumatic stress disorder.
F. Martényi, E. Brown, Harry Zhang, A. Prakash +1 more
2002Journal of Clinical Psychiatry191 citations
Semantic Scholar
The Potent BACE1 Inhibitor LY2886721 Elicits Robust Central Aβ Pharmacodynamic Responses in Mice, Dogs, and Humans
P. May, B. Willis, S. Lowe, R. Dean +27 more
2015Journal of Neuroscience165 citations Open access
Semantic Scholar
Gender differences in the efficacy of fluoxetine and maprotiline in depressed patients: a double-blind trial of antidepressants with serotonergic or norepinephrinergic reuptake inhibition profile.
F. Martényi, M. Dossenbach, K. Mraz, Stephen Metcalfe
2001European Neuropsychopharmacology162 citations
Semantic Scholar
Fluoxetine v. placebo in prevention of relapse in post-traumatic stress disorder
F. Martényi, E. Brown, Harry Zhang, S. Koke +1 more
2002British Journal of Psychiatry128 citations Open access
Semantic Scholar
Measuring cognition and function in the preclinical stage of Alzheimer's disease
S. Weintraub, M. Carrillo, S. Farias, T. Goldberg +15 more
2018Alzheimer's & Dementia117 citations Open access
Semantic Scholar
Olanzapine plus carbamazepine v. carbamazepine alone in treating manic episodes
M. Tohen, C. Bowden, A. Smulevich, R. Bergstrom +7 more
2008British Journal of Psychiatry79 citations Open access
Semantic Scholar
Fluoxetine in the acute treatment and relapse prevention of combat-related post-traumatic stress disorder: Analysis of the veteran group of a placebo-controlled, randomized clinical trial.
F. Martényi, V. Soldatenkova
2006European Neuropsychopharmacology76 citations
Semantic Scholar
Failed Efficacy of Fluoxetine in the Treatment of Posttraumatic Stress Disorder: Results of a Fixed-Dose, Placebo-Controlled Study
F. Martényi, E. Brown, C. Caldwell
2007Journal of Clinical Psychopharmacology75 citations
Semantic Scholar
An efficacy analysis of olanzapine treatment data in schizophrenia patients with catatonic signs and symptoms.
F. Martényi, Stephen Metcalfe, Barbara Schausberger, M. Dossenbach
2001Journal of Clinical Psychiatry52 citations
Semantic Scholar
Enriching Amnestic Mild Cognitive Impairment Populations for Clinical Trials: Optimal Combination of Biomarkers to Predict Conversion to Dementia
P. Yu, R. Dean, S. Hall, Yuan Qi +6 more
2012Journal of Alzheimer's Disease46 citations Open access
Semantic Scholar
A Consensus Meeting on Effective Research Practice in PTSD
D. Charney, J. Davidson, M. Friedman, R. Judge +11 more
1998CNS Spectrums35 citations
Semantic Scholar
Validation of a Multiplex Assay for Simultaneous Quantification of Amyloid-β Peptide Species in Human Plasma with Utility for Measurements in Studies of Alzheimer's Disease Therapeutics
D. R. Lachno, Julie K. Emerson, H. Vanderstichele, C. Gonzales +6 more
2012Journal of Alzheimer's Disease34 citations
Semantic Scholar
Atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder: a 6-week, randomized, placebo-controlled, double-blind trial in Russia
F. Martényi, N. Zavadenko, N. Jarkova, A. A. Yarosh +8 more
2009European Child and Adolescent Psychiatry33 citations
Semantic Scholar
Mood effect of raloxifene in postmenopausal women.
N. Jarkova, F. Martényi, D. Masanauskaite, E. Walls +2 more
2002Maturitas33 citations
Semantic Scholar
Attention-deficit/hyperactivity disorder diagnosis, co-morbidities, treatment patterns, and quality of life in a pediatric population in central and eastern Europe and Asia.
F. Martényi, T. Treuer, S. Gau, S. Hong +9 more
2009Journal of child and adolescent psychopharmacology32 citations
Semantic Scholar
Antipsychotic prescription patterns in outpatient settings: 24-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study.
I. Bitter, T. Treuer, Y. Dyachkova, F. Martényi +2 more
2008European Neuropsychopharmacology25 citations
Semantic Scholar
P3‐363: BACE inhibitor LY2886721 safety and central and peripheral PK and PD in healthy subjects (HSs)
F. Martényi, Robert A. Dean, S. Lowe, M. Nakano +11 more
201223 citations Open access
Semantic Scholar
O1‐09‐02: THE EFFECT OF LOW DOSES OF GANTENERUMAB ON AMYLOID AND TAU BIOMARKERS IN CEREBROSPINAL FLUID (CSF) IN THE MARGUERITE ROAD STUDY
N. Voyle, D. Abi‐Saab, G. Klein, C. Hofmann +7 more
201821 citations
Semantic Scholar
O1‐09‐04: UPDATE ON THE SAFETY AND TOLERABILITY OF GANTENERUMAB IN THE ONGOING OPEN‐LABEL EXTENSION (OLE) OF THE MARGUERITE ROAD STUDY IN PATIENTS WITH MILD ALZHEIMER'S DISEASE (AD) AFTER APPROXIMATELY TWO YEARS OF STUDY DURATION
D. Abi‐Saab, M. Andjelkovic, N. Pross, P. Delmar +7 more
201820 citations
Semantic Scholar
O1‐09‐05: UPDATE ON THE SAFETY AND TOLERABILITY OF GANTENERUMAB IN THE ONGOING OPEN‐LABEL EXTENSION OF THE SCARLET ROAD STUDY IN PATIENTS WITH PRODROMAL ALZHEIMER'S DISEASE AFTER APPROXIMATELY 2 YEARS OF STUDY DURATION
M. Andjelkovic, D. Abi‐Saab, P. Delmar, N. Pross +7 more
201819 citations
Semantic Scholar
Safety, pharmacokinetics and quantitative EEG modulation of TAK‐071, a novel muscarinic M1 receptor positive allosteric modulator, in healthy subjects
W. Yin, Fahimeh Mamashli, D. Buhl, P. Khudyakov +5 more
2021British Journal of Clinical Pharmacology15 citations Open access
Semantic Scholar
A 12-Month Prospective, Observational Study of Treatment Regimen and Quality of Life Associated With ADHD in Central and Eastern Europe and Eastern Asia
Michal Goetz, C. Yeh, I. Ondrejka, A. Akay +8 more
2012Journal of Attention Disorders15 citations
Semantic Scholar
Clonazepam for the treatment of stupor in catatonic schizophrenia.
F. Martényi, J. Harangozó, L. Mód
1989American Journal of Psychiatry14 citations
Semantic Scholar
Exploratory digital outcome measures of motor sign progression in Parkinson’s disease patients treated with prasinezumab
K. Taylor, F. Lipsmeier, M. A. Scelsi, E. Volkova-Volkmar +308 more
2025npj Digital Medicine12 citations Open access
Semantic Scholar
Corrigenda: Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial
Sandeep T. Patil, Lu Zhang, F. Martényi, S. Lowe +14 more
2007Nature Medicine12 citations Open access
Semantic Scholar
A prospective observational study of attention-deficit hyperactivity disorder in Asia: baseline characteristics of symptom severity and treatment options in a paediatric population.
F. Martényi, Yi Zheng, Yu-Shu Huang, Yong-sik Lee +3 more
2010East Asian Archives of Psychiatry10 citations
Semantic Scholar
Factors associated with achieving minimally symptomatic status by patients with schizophrenia: results from the 3‐year intercontinental schizophrenia outpatients health outcomes study
T. Treuer, F. Martényi, M. Şaylan, Y. Dyachkova
2010International journal of clinical practice10 citations Open access
Semantic Scholar
Parasitosis, dopaminergic modulation and metabolic disturbances in schizophrenia: evolution of a hypothesis.
T. Treuer, F. Martényi, J. Karagianis
2007Neuro - endocrinology letters9 citations
Semantic Scholar
P4‐089: Investigating Astrocytes With C11‐deuterium Deprenyl in Mild Cognitive Impairment and Mild Alzheimer's ‐ A Multi‐tracer Positron Emission Tomography Paradigm
F. Martényi, Stephen L. Lowe, Robert A. Dean, S. Monk +11 more
20108 citations Open access
Semantic Scholar
PRX005, a novel anti‐MTBR tau monoclonal antibody: results from a first‐in‐human double‐blind, placebo‐controlled, single ascending dose phase 1 study
F. Martényi, Brian Campbell, Gene G. Kinney, Jun Lee +3 more
2023Alzheimer's & Dementia7 citations Open access
Semantic Scholar
A prospective observational study of attention-deficit/hyperactivity disorder in Central and Eastern Europe and Turkey: Symptom severity and treatment options in a paediatric population
I. Ondrejka, O. Abali, I. Paclt, Magdolna Gácser +5 more
2010International journal of psychiatry in clinical practice7 citations
Semantic Scholar
Predictive value of early antianxiety effect on the acute-antipsychotic outcome: A comparison of fluphenazine and olanzapine
F. Martényi, M. Dossenbach, M. Jakovljević, Stephen Metcalfe
20006 citations
Semantic Scholar
O1‐06‐01: Central BACE1 inhibition by LY2886721 produces opposing effects on APP processing as reflected by cerebrospinal fluid sAPP‐alpha and sAPP‐beta
Brian A. Willis, F. Martényi, Robert A. Dean, Stephen L. Lowe +7 more
20125 citations Open access
Semantic Scholar
Olanzapine versus chlorpromazine in Turkey
K. Mraz, A. Göğüş, Z. Tunca, F. Martényi +1 more
20005 citations
Semantic Scholar
Olanzapine versus clozapine in patients non-responsive or intolerant to standard acceptable treatment of schizophrenia
I. Bitter, S. Brook, M. Dossenbach, Z. Janka +4 more
19995 citations
Semantic Scholar
Sleep quality during fluoxetine therapy in depression
M. Dossenbach, F. Martényi, E. De Verga
19975 citations
Semantic Scholar
Gender differences in the antidepressive effect? A double blind trial of fluoxetine and maprotiline in the treatment of major depression
F. Martényi, M. Dossenbach, K. Mraz, Stephen Metcalfe
20004 citations
Semantic Scholar
[The use of mGlu2/3 receptors as a new approach to treat schizophrenia: results of a randomized double-blind trial].
S. Mosolov, A. Smulevich, N. G. Neznanov, V. A. Tochilov +7 more
2010Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova3 citations
Semantic Scholar
Sleep quality and early morning wakefulness of schizophrenic patients treated with olanzapine compared to chlorpromazine
E. Kostakoglu, K. Alptekin, B. Kivircik, F. Martényi +3 more
20003 citations
Semantic Scholar
THE EFFECT OF LOW DOSES OF GANTENERUMAB ON AMYLOID AND TAU BIOMARKERS IN CEREBROSPINAL FLUID (CSF) IN THE MARGUERITE ROAD STUDY 24-MONTH AMYLOID PET RESULTS OF THE GANTENERUMAB HIGH-DOSE OPEN LABEL EXTENSION STUDIES
D. Abi‐Saab, G. Klein, C. Hofmann, P. Delmar +9 more
20182 citations
Semantic Scholar
[Three paradigms in the treatment of posttraumatic stress disorder].
F. Martényi
2005Neuropsychopharmacologia Hungarica2 citations
Semantic Scholar
Phase 1 Single and Multiple Dose Clinical Trials (ASCENT‐1 and ASCENT‐2) for Dose‐Finding of PRX012 in Participants with Biologically Confirmed Alzheimer’s Disease
Chad Swanson, F. Martényi, Ryan E. Tooker, Brian Campbell +6 more
2024Alzheimer's & Dementia1 citations Open access
Semantic Scholar
[P1–059]: APPROACHES TO SUBJECT RETENTION IN A PHASE 3 DELAY‐OF‐ONSET OF MILD COGNITIVE IMPAIRMENT DUE TO ALZHEIMER's DISEASE (MCI‐AD) CLINICAL TRIAL: THE TOMMORROW STUDY EXPERIENCE
K. Welsh-Bohmer, B. Plassman, Carl Chiang, Meredith Culp +13 more
20171 citations
Semantic Scholar
Pharmacokinetic (PK) and Pharmacodynamic (PD) Effects of BACE Inhibitor LY2886721 in Healthy Volunteers (HVs) at Steady State (P01.017)
F. Martényi, Brian A. Willis, Robert Dean, C. Gonzales +7 more
2013Neurology1 citations
Semantic Scholar
mGlu2/3 Agonists – a New Approach to the Treatment of Schizophrenia: Results of a Randomized Double-Blind Trial
S. Mosolov, A. Smulevich, N. G. Neznanov, V. Tochilov +7 more
2011Neuroscience and Behavioral Physiology1 citations
Semantic Scholar
P.7.c.003 Atomoxetine in the treatment of psychostimulant-naive children and adolescents with ADHD: a 6-week, randomized, placebo-controlled trial in Russia
F. Martényi, N. Zavadenko, N. Jarkova
20061 citations
Semantic Scholar
Clinical Research in Psychopharmacology
F. Martényi, R. Spiegel
20051 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

C. Gonzales×7
Invite
C. Gonzales — researcher profile on SciRah
S. Monk×6
Invite
S. Monk — researcher profile on SciRah
T. Treuer×6
Invite
T. Treuer — researcher profile on SciRah
S. Lowe×5
Invite
S. Lowe — researcher profile on SciRah

×5

Invite

A. Smulevich — researcher profile on SciRah

Invite

D. Mergott — researcher profile on SciRah

M. Dossenbach×5

Invite

M. Dossenbach — researcher profile on SciRah

Invite

R. Doody — researcher profile on SciRah

Invite

B. Andreev — researcher profile on SciRah

A. Avedisova×4

Invite

A. Avedisova — researcher profile on SciRah

N. G. Neznanov×4

Invite

N. G. Neznanov — researcher profile on SciRah

Invite

A. Reznik — researcher profile on SciRah